ALLO vs HAS · rev $22.0K vs P/E 25, rev $4.75B
Allogene Therapeutics Inc (ALLO) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
ALLO currently screens at market cap $258.1M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the ALLO and HAS stock pages for the full models.
Not investment advice.